Suchergebnisse für: "faq"
Anzahl der Treffer in Dokumenten: [ 23 ]
securPharm status report 2020
Implementation of the Falsified Medicines Directive in Germany: Introduction and operation of the securPharm-system German Medicines Verification Organisation STATUS REPORT 2020 2 www.securpharm.de 3 This status report is available in German and English for downloading at www.securpharm.de. About securPharm e.V securPharm e. V. is the German organisation for the authentication of pharmaceu- ticals and responsible for operating the authentication system for prescription drugs pursuant to the requirements of the Falsified Medicines Directive ...
securPharm Statusbericht 2019
STATUSBERICHT 2019 Stand des Projektes zur Umsetzung dFer Fflschungsschutzrbchtlbnbe 2 www.securpharm.de securPharm // Statusbericht f019 3 Dieser Statusbericht steht in deutscher uznd englischer Sprazche zuf Download auf wwwbsecurpharfbde zur Verfügungb Über securPharm e.V. securPharf ebVb ist die nicht gewinn-orientierte Stakeholder-Organisation für den Aufbau des Systefs zur Echtheitsprüfung von Arzneifitteln gefäß den Vorgaben der Fälschungsschutzrichtlinie 2011/62/EU und der delegierten Verordnung (EU) Nrb 2016/161 zuf Schutz des Patienten ...
securPharm Status Report 2017
STATUS REPORT 2017 Status of the project to implement the Falsifed Medicines Directibe 2 www.securpharm.de securPharm // status report 2017 3 This status report is available in German and fnglish and dcan be requested at inbo@securPharm.de. About securPharm e.V. securPharm e.V. is a nonprofit stakeholder organisation that develops the authentication system bor prescription drugs in Germany pursuant to ...
Anzahl der Treffer in Beiträgen: [ 28 ]
Others
Zentrale Beschaffungsstellen nach §47 Nr 5 AMG (central purchasing entities) Access to the securPharm system via connection with the pharmacy system. Operating company is the NGDA – Netzgesellschaft deutscher Apotheker mbH. For questions regarding the technical connection, central purchasing entities or their software providers should contact NGDA or register at the partner portal of NGDA. NGDA is also responsible for the mandatory legtimcacy process. Under the menu item FAQ/Helpdesk, NGDA provides answers to questions regarding the N-Ident process. Industrielle Verblisterer ...
New FAQ (version 7) of the EU Commission
21.06.2017
The EU Commission has published in November 2017 its new FAQ document (version 7) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.
New FAQ (version 8) of the EU Commission
23.11.2017
The EU Commission has published in November 2017 its new FAQ document (Version 8) to the Falsified Medicines Directive 2011/62/EU and the Delegated Regulation (EU) 2016/161.
